Digital Diagnostics Market is Expected to Grow at 15% by 2031. Digital diagnostic is also known as digital immune system, because it helps to improve medical care system by contributing in the precision and accuracy of the diagnostics output. Market experts suggest that through digital diagnostics, automated health assessments can be carried out virtually and electronically. The geographical barriers can be reduced with this technology by making it possible to diagnose patients located away from the clinic. Currently, several companies have developed their respective mobile applications and software programs to make remote diagnostics possible. In the near future, it is anticipated that more advanced high-end programs will be created by the companies to diagnose patients without their physical presence in the diagnostic facility. The current available products in digital diagnosis market comprises Oxitone (Oxitone Medical Ltd.), Cerora Borealis (Cerora), Oto (CellScope), Midmark IQvitals, IQecg, IQholter, IQspiro and IQstress (MidMark Corp.), Intelligent Breast Exam (iBE) (UE LifeSciences, Inc.), Fever Smart (Fever Smart) and others.  

The key drivers assisting the overall market growth of digital diagnostics are increasing awareness related to lifestyle diseases diagnostics, bed ridden patients are expected to prefer digital diagnostic over laboratory visit, and this technology is anticipated to increase the accessibility for patients as well as medical practitioners. North America is the leading regional market for digital diagnostics and is trailed by Europe due to the existence of a large number of population suffering with diseases, and high patient awareness related to disease diagnosis in these regions. Some countries from Asia–Pacific and Latin America are expected to enter the market late because of lack of digital infrastructure, and accessibility to advanced technology. However, rising healthcare expenditure, developing healthcare infrastructure and increasing awareness related to the disease diagnosis.

The global digital diagnostics market is segmented on the following bases:

Key Players Identified for Digital Diagnostics Market Include but are Not Limited to:

F. Hoffmann-La Roche Ltd., GE Healthcare, Siemens Healthcare GmbH, ThermoFisher Scientific Inc., and Laboratory Corporation of America Holdings, among others.